DSIP / Selank
Comparing DSIP and Selank by measurement
The most useful comparison starts with what went into the assay or the recording. A shared interest in stress leaves plenty of room for different results.
The measurements alongside one another
I lose the useful distinctions when a DSIP–Selank scorecard reads sleep versus calm. DSIP's hormone experiment and Selank's immune study are more specific and more revealing. Their findings come from different experiments, with different subjects and endpoints.
| Experiment | DSIP | Selank |
|---|---|---|
| Human blood measurements | ACTH-like immunoreactivity fell; cortisol was unaffected in men | Th1/Th2 balance and IL-6 expression changed in patients with anxiety-asthenic disorders |
| Sleep measurements | Delta and spindle EEG activity increased in rabbits; a small insomnia pilot reported improved sleep in people | The molecular review addresses anxiety mechanisms; a dependable human sleep benefit remains unestablished |
| Animal stress-related work | Motor recovery improved after focal stroke in rats, without a significant infarct-volume difference | Selank plus diazepam reduced anxiety-related behavior most strongly in chronically stressed rats |
Origin and mechanism
DSIP's nine-amino-acid sequence came from rabbit blood. The later review describes enduring uncertainty about its receptor, precursor and physiological role. Selank's seven-amino-acid chain was designed by extending tuftsin, with GABA-related modulation and enkephalin stabilization among its proposed mechanisms.
That is a real difference in mechanistic detail. I still can't connect the hormone and cytokine measurements to a shared clinical outcome. Neither a cytokine shift nor an ACTH assay establishes a general recovery benefit. A connection worth investigating can remain an open question.
Clinical limits and combinations
Neither compound has FDA or EMA approval; Selank is registered as a prescription anxiolytic in Russia. U.S. compounded prescription forms have no FDA approval. Research-labelled supplies carry separate uncertainties about identity, content, purity and sterility.
The human evidence is small and uneven, as the DSIP review and Selank review make clear. There are no established human combination-safety data for DSIP with Selank. The diazepam finding above concerns rats and a different pairing. A combined-use plan would require evidence about the proposed pairing.
The DSIP and Selank pages contain the individual experiments and safety questions. The FAQ covers the recurring practical questions without supplying a dose or schedule.